网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
癫痫患者ABCC2基因多态性与丙戊酸钠血药浓度、疗效的相关性分析
作者:刘永刚1  张学勇2  吴佳欢3 
单位:1. 佳木斯大学附属第一医院 神内三科, 黑龙江 佳木斯 154000;
2. 佳木斯市二二四医院 内一科, 黑龙江 佳木斯 154000;
3. 佳木斯大学附属第一医院 神内一科, 黑龙江 佳木斯 154000
关键词:癫痫 ATP结合盒式家族C成员2 基因多态性 丙戊酸钠 血药浓度 临床疗效 
分类号:R742.1
出版年·卷·期(页码):2019·47·第六期(646-651)
摘要:

目的:探究癫痫患者ATP结合盒式家族C成员2(ABCC2)基因多态性与丙戊酸钠血药浓度、药效的关系,为癫痫临床治疗提供参考。方法:收集佳木斯大学附属第一医院137例癫痫患者血液样本,高效液相色谱(HPLC)法检测丙戊酸钠血药浓度,限制性片段长度多态性-聚合酶链式反应检测ABCC2基因位点rs717620、rs3740066基因型,对比位点不同基因分型患者标准化血药浓度以及临床疗效差异。结果:rs717620、rs3740066存在单核苷酸多态性,均为野生型纯合子CC型、突变杂合子CT型、突变纯合子TT型。rs717620、rs3740066基因多态性基因型频率分布符合Hardy-weinberg定律。rs717620基因型CC型患者标准化血药浓度、血药剂量、临床有效率高于基因型CT、TT型以及CT+TT型(P<0.05)。rs3740066基因型CC型患者标准化血药浓度、血药剂量、临床有效率高于基因型CT、TT型以及CT+TT型(P<0.05)。结论:ABCC2基因rs717620、rs3740066位点基因多态性与丙戊酸钠血药浓度、临床疗效有关,此两处位点发生突变可能导致血药浓度降低、疗效下降。

Objective:To explore the relationships between the gene polymorphism of ATP-binding cassette-2 (ABCC2) with the blood concentration of sodium valproate and pesticide effect in patients with epilepsy, in order to provide some reference for the clinical treatment of epilepsy. Methods:Blood samples of 137 epileptic patients in the First Affiliated Hospital of Jiamusi University were collected, the blood concentration of sodium valproate was determined by high performance liquid chromatography (HPLC),the ABCC2 loci rs717620 and rs3740066 genotypes were detected by restriction fragment length polymorphism-polymerase chain reaction, the differences of standardized blood concentration and clinical efficacy between different genotyping patients were compared. Results:There were single nucleotide polymorphisms in rs717620 and rs3740066, they were wild type homozygote CC type, mutant heterozygote CT type and mutant homozygous TT type. The frequency distributions of rs717620 and rs3740066 polymorphisms were consistent with Hardy-weinberg law. The standardized blood concentration, blood dose and clinical effective rate of rs717620 genotype CC patients were higher than those of genotype CT, TT and CT+TT patients (P<0.05). The standardized blood concentration, blood dose and clinical effective rate of rs3740066 genotype CC patients were higher than those of genotype CT, TT and CT+TT patients (P<0.05). Conclusion:The polymorphisms of ABCC2 gene rs717620 and rs3740066 loci are related to the serum concentration of sodium valproate and clinical efficacy.The mutation of rs717620 and rs3740066 loci can lead to the decrease of blood drug concentration and curative effect.

参考文献:

[1] 杨樟,徐祖才.预防性抗癫痫药物治疗研究进展[J].重庆医科大学学报,2016,41(1):5-7.
[2] 严峻,高作惠,龚传鹏,等.喹硫平联合丙戊酸钠对首发性精神分裂症伴有冲动与攻击行为患者兴奋躁动的影响[J].东南大学学报(医学版),2015,34(4):148-150.
[3] 丁媛媛,杨凡,刘静,等.多药耐药基因单倍体对中国癫痫患者丙戊酸钠血药浓度的影响[J].中国临床药理学与治疗学,2010,15(11):1267-1272.
[4] 李甲,陈宝安.抑制P-糖蛋白转运体功能在逆转肿瘤多药耐药中的研究现状及进展[J].东南大学学报(医学版),2018,37(2):359-363.
[5] JUAN-TOGORES J M,WILLIAM G.Lennox and the International Anti-Epilepsy League:a description of his life and work[J].Revista De Neurologia,1998,26(154):1074-1075.
[6] 庹虎,姚宝珍,刘小雪,等.癫痫患儿行为障碍及影响因素分析[J].现代医学,2014,42(1):30-33.
[7] 陈娟,王雪丁,周列民,等.转运体基因多态性对癫痫患者丙戊酸血药浓度及临床疗效的影响[J].中国临床药理学杂志,2016,32(3):215-217.
[8] CUFFE S,AZAD A K,QIU X,et al.ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients[J].Cancer Epidemiology,2016,41(4):50-56.
[9] 王丹,魏玉辉,周燕,等.基于多药耐药相关蛋白2(Abcc2/Mrp2)在大鼠肾脏表达性别差异的氧氟沙星药动学变化[J].药学学报,2012,47(5):624-629.
[10] 韩志刚,马玲,陶洁,等.新疆维吾尔族晚期非小细胞肺癌GSTP1、ABCC2基因多态性与含铂方案化疗敏感性的研究[J].临床肿瘤学杂志,2015,20(1):23-29.
[11] GROVER S,KUKRETI R.A systematic review and meta-analysis of the role of ABCC2,variants on drug response in patients with epilepsy[J].Epilepsia,2013,54(5):936-945.
[12] AKIYAMA Y,FUJITA K,ISHIDA H,et al.Association of ABCC2 genotype with efficacy of first-line FOLFIRI in Japanese patients with advanced colorectal cancer[J].Drug Metab Pharmacokinet,2012,27(3):325-335.
[13] MA C L,WU X Y,JIAO Z,et al.SCN1A,ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy[J].Pharmacogenomics,2015,16(4):347-360.
[14] 张致庆,徐虹.基因多态性对儿童霉酚酸酯个体化治疗的意义[J].临床儿科杂志,2018,38(5):259-261.
[15] 韩志刚,陶洁,王强,等.新疆地区维吾尔族和汉族晚期非小细胞肺癌患者三磷酸腺苷结合盒转运体C2基因多态性差异研究[J].实用心脑肺血管病杂志,2015,27(3):38-42.
[16] GARCÍA S G,RAMOS R D,NAZCO G C,et al.Effect of UGT,SLCO,ABCB and ABCC polymorphisms on irinotecan toxicity[J].Med Clin,2018,137(8):489-496.
[17] 刘思婷,李晓蕾,张永,等.ABCB1和ABCC2及SLCO1B1基因多态性与大剂量甲氨蝶呤化疗毒性作用的相关性[J].中华检验医学杂志,2014,37(1):60-65.
[18] ZHOU L,CAO Y,LONG H,et al.ABCB1,ABCC2,SCN1A,SCN2A,GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population[J].Die Pharmazie,2015,70(6):416-420.
[19] 李银英,张涛志.ABCC2-24C>T基因多态性对中国癫痫患者卡马西平剂量和血药浓度的影响[J].中国实用神经疾病杂志,2016,19(8):75-77.
[20] DI F R,SIESTO R S,VALENTE D,et al.Current strategies to minimize toxicity of oxaliplatin:selection of pharmacogenomic panel tests[J].Anticancer Drugs,2013,24(10):1069-1078.
[21] ROSNER G L,PANETTA J C,INNOCENTI F,et al.Pharmacogenetic pathwayanalysis of irinotecan[J].Clin Pharmacol Ther,2008,84(5):393-402.
[22] SHA'ARI H M,HAERIAN B S,BAUM L,et al.ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to antiepileptic drugs in Asia Pacific epilepsy cohorts[J].Pharmacogenomics,2014,15(4):459-466.
[23] LOPEZ-LOPEZ E,GUTIERREZ-CAMINO A,ASTIGARRAGA I,et al.Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia[J].Pharmacogenomics,2016,17(7):731-741.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 747237 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541